Clinical Trials for Unresectable Hepatocellular Carcinoma (HCC)

Find clinical trials for unresectable hepatocellular carcinoma (hcc). Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.

NCT ID: NCT06739317

This clinical trial is studying a new treatment approach for patients with unresectable hepatocellular carcinoma (HCC), which is a type of liver cancer that cannot be surgically removed. The trial ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

NCT ID: NCT05967143

The SIRtain Registry is a clinical trial that is studying the use of a treatment called SIR-Spheres for patients with certain types of liver tumors that cannot be removed with surgery. Specifically...

Recruiting

Type: observational Locations: Valencia, , Spain, London, , United Kingdom +8 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions